Christopher K. Scott - Nov 15, 2021 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
COO, CFO & Secretary
Signature
/s/ Christopher K. Scott
Stock symbol
IRMD
Transactions as of
Nov 15, 2021
Transactions value $
-$250,095
Form type
4
Date filed
11/17/2021, 05:19 PM
Previous filing
Jul 12, 2021
Next filing
Nov 24, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Award $19.9K +2.03K +7.09% $9.84 30.6K Nov 15, 2021 Direct
transaction IRMD Common Stock Sale -$81.3K -2.03K -6.62% $40.10 28.6K Nov 15, 2021 Direct F1
transaction IRMD Common Stock Award $41.9K +4.26K +14.88% $9.84 32.9K Nov 16, 2021 Direct
transaction IRMD Common Stock Sale -$170K -4.26K -12.95% $40.00 28.6K Nov 16, 2021 Direct
transaction IRMD Common Stock Award $19.7K +2K +7% $9.84 30.6K Nov 17, 2021 Direct
transaction IRMD Common Stock Sale -$80.1K -2K -6.55% $40.01 28.6K Nov 17, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Employee Stock Option (Right to Buy) Options Exercise $0 -2.03K -5.79% $0.00 33K Nov 15, 2021 Common Stock 2.03K $9.84 Direct F3
transaction IRMD Employee Stock Option (Right to Buy) Options Exercise $0 -4.26K -12.9% $0.00 28.7K Nov 16, 2021 Common Stock 4.26K $9.84 Direct F3
transaction IRMD Employee Stock Option (Right to Buy) Options Exercise $0 -2K -6.97% $0.00 26.7K Nov 17, 2021 Common Stock 2K $9.84 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $40.00 to $41.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $40.00 to $40.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.
F3 This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.